Treatment Results on Patients With Debridement and Prosthesis Retention in the Hip

This study has been completed.
Sponsor:
Information provided by:
Sorlandet Hospital HF
ClinicalTrials.gov Identifier:
NCT00757445
First received: September 22, 2008
Last updated: NA
Last verified: September 2008
History: No changes posted
  Purpose

This study presents the investigators results on patients treated for infection in the implemented hip prosthesis. Debridement and prosthesis retention is the method, followed by antibiotic treatment. The investigators present treatment results, predisposing factors and microbiological data.


Condition
Infection
Debridement With Prosthesis Retention

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Treatment Results on Patients With Debridement and Prosthesis Retention in the Hip 1997-2007

Further study details as provided by Sorlandet Hospital HF:

Enrollment: 105
Study Start Date: January 1997
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   15 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with prosthesis infection in hip

Criteria

Inclusion Criteria:

  • Infection in prothesis in hip treated with debridement and prosthesis retention

Exclusion Criteria:

  • Other technique
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00757445

Locations
Norway
Sorlandet Hospital HF
Kristiansand, Agder, Norway, 4600
Sponsors and Collaborators
Sorlandet Hospital HF
Investigators
Principal Investigator: Bjoern Waagsboe, MD Sorlandet Hospital HF
  More Information

No publications provided

Responsible Party: Bjoern Waagsboe, Sorlandet Sykehus HF
ClinicalTrials.gov Identifier: NCT00757445     History of Changes
Other Study ID Numbers: Sorlandet Hospital HF
Study First Received: September 22, 2008
Last Updated: September 22, 2008
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Sorlandet Hospital HF:
Antibiotic therapy
Microbiological diagnosis

ClinicalTrials.gov processed this record on September 30, 2014